Herbal constituent sequoyitol improves hyperglycemia and glucose intolerance by targeting hepatocytes, adipocytes, and β-cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 8, 2012, Pages

  Shen, Hong ^a   Shao, Mengle ^b   Cho, Kae Won ^a   Wang, Suqing ^a   Chen, Zheng ^a   Sheng, Liang ^a   Wang, Ting ^c   Liu, Yong ^b   Rui, Liangyou ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c Xiangbei Welman Pharmaceutical Co Ltd   (China)

Author keywords

Diabetes; Hyperglycemia; Insulin resistance

Indexed keywords

GLUCOSE; INOSITOL DERIVATIVE; INSULIN; ORAL ANTIDIABETIC AGENT; SEQUOYITOL; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG TARGETING; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; IMMUNOPRECIPITATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADIPOCYTES, WHITE; ANIMALS; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE INTOLERANCE; HEPATOCYTES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INOSITOL; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; PROTECTIVE AGENTS; RATS; SIGNAL TRANSDUCTION;

EID: 84859470850     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00479.2011     Document Type: Article

References (45)

1. Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047-9054, 2000.
2. Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem 277: 1531-1537, 2002.
3. Asplin I, Galasko G, Larner J. chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol- containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci U S A 90: 5924-5928, 1993.
4. Bates SH, Jones RB, Bailey CJ. Insulin-like effect of pinitol. Br J Pharmacol 130: 1944-1948, 2000.
5. Brautigan DL, Brown M, Grindrod S, Chinigo G, Kruszewski A, Lukasik SM, Bushweller JH, Horal M, Keller S, Tamura S, Heimark DB, Price J, Larner AN, Larner J. Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action. Biochemistry 44: 11067-11073, 2005.
6. Cefalu WT, Ye J, Wang ZQ. Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr Metab Immune Disord Drug Targets 8: 78-81, 2008.
7. Cheang KI, Baillargeon JP, Essah PA, Ostlund RE Jr, Apridonize T, Islam L, Nestler JE. Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metabolism 57: 1390-1397, 2008.
8. Chen ZH, Li J, Liu J, Zhao Y, Zhang P, Zhang MX, Zhang L. Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice. Am J Chin Med 36: 939-951, 2008.
9. Cho KW, Zhou Y, Sheng L, Rui L. Lipocalin-13 regulates glucose metabolism by both insulin-dependent and insulin-independent mechanisms. Mol Cell Biol 31: 450-457, 2011.
10. Dang NT, Mukai R, Yoshida K, Ashida H. D-Pinitol and myo-inositol stimulate translocation of glucose transporter 4 in skeletal muscle of C57BL/6 mice. Biosci Biotechnol Biochem 74: 1062-1067, 2010.
11. De Camilli P, Emr SD, McPherson PS, Novick P. Phosphoinositides as regulators in membrane traffic. Science 271: 1533-1539, 1996.
12. Francisco MC, Nasser AL, Lopes LM. Tetrahydroisoquinoline alkaloids and 2-deoxyribonolactones from Aristolochia arcuata. Phytochemistry 62: 1265-1270, 2003.
13. 2-dependent glycogen synthase phosphatase (phosphoprotein phosphatase IA) from rat liver. Eur J Biochem 119: 503-510, 1981.
14. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB. Isolation of INS-1-derived cell lines with robust ATP- sensitive K channel-dependent and-independent glucose-stimulated insulin secretion. Diabetes 49: 424-430, 2000.
15. Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 107: 119-125, 1999.
16. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A 91: 4854-4858, 1994.
17. Huyen VT, Phan DV, Thang P, Hoa NK, Ostenson CG. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm Metab Res 42: 353-357, 2010.
18. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284: E671-E678, 2003.
19. Kang MJ, Kim JI, Yoon SY, Kim JC, Cha IJ. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. J Med Food 9: 182-186, 2006.
20. Kawa JM, Przybylski R, Taylor CG. Urinary chiro-inositol and myoinositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat. Exp Biol Med (Maywood) 228: 907-914, 2003.
21. Kunjara S, Wang DY, Greenbaum AL, McLean P, Kurtz A, Rademacher TW. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol Genet Metab 68: 488-502, 1999.
22. Kuriyan R, Rajendran R, Bantwal G, Kurpad AV. Effect of supplementation of Coccinia cordifolia extract on newly detected diabetic patients. Diabetes Care 31: 216-220, 2008.
23. Larner J, Brautigan DL, Thorner MO. D-Chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med 16: 543-552, 2010.
24. Li SH, Zhang HJ, Niu XM, Yao P, Sun HD, Fong HH. Chemical constituents from Amentotaxus yunnanensis and Torreyayunnanensis. J Nat Prod 66: 1002-1005, 2003.
25. Lilley K, Zhang C, Villar-Palasi C, Larner J, Huang L. Insulin mediator stimulation of pyruvate dehydrogenase phosphatases. Arch Biochem Biophys 296: 170-174, 1992.
26. Marchetti P, Lupi R, Del Guerra S, Bugliani M, Marselli L, Boggi U. The beta-cell in human type 2 diabetes. Adv Exp Med Biol 654: 501-514, 2010.
27. McLean P, Kunjara S, Greenbaum AL, Gumaa K, Lopez-Prados J, Martin-Lomas M, Rademacher TW. Reciprocal control of pyruvate dehydrogenase kinase and phosphatase by inositol phosphoglycans. Dynamic state set by "push-pull" system. J Biol Chem 283: 33428-33436, 2008.
28. Michell RH. Inositol derivatives: evolution and functions. Nat Rev Mol Cell Biol 9: 151-161, 2008.
29. Nestler JE, Jakubowicz DJ, Iuorno MJ. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome. J Pediatr Endocrinol Metab 13, Suppl 5: 1295-1298, 2000.
30. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 271: 13018-13022, 1996.
31. Ren D, Li M, Duan C, Rui L. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab 2: 95-104, 2005.
32. Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest 117: 397-406, 2007.
33. Rui L, Aguirre V, Kim JK, Shulman GI, Lee A, Corbould A, Dunaif A, White MF. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest 107: 181-189, 2001.
34. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414: 799-806, 2001.
35. Sivakumar S, Palsamy P, Subramanian SP. Attenuation of oxidative stress and alteration of hepatic tissue ultrastructure by D-pinitol in strep-tozotocin-induced diabetic rats. Free Radic Res 44: 668-678, 2010.
36. Sleight S, Wilson BA, Heimark DB, Larner J. G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles. Biochem Biophys Res Commun 295: 561-569, 2002.
37. Uysal KT, Wiesbrock SM, Hotamisligil GS. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 139: 4832-4838, 1998.
38. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614, 1997.
39. van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112-124, 2008.
40. Vanhaesebroeck B, Leevers SJ, Panayotou G, Waterfield MD. Phos-phoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci 22: 267-272, 1997.
41. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, Simpson HC. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br J Gen Pract 56: 437-443, 2006.
42. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283: E413-E422, 2002.
43. Yang XW, Zou L, Wu Q, Fu DX. [Studies on chemical constituents from whole plants of Crossostephium chinense]. Zhongguo Zhong Yao Za Zhi 33: 905-908, 2008.
44. Zhou Y, Jiang L, Rui L. Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J Biol Chem 284: 11152-11159, 2009.
45. Zou L, Wu Q, Yang X, Fu D. [Effects of chemical constituents of Crossostephium chinense on insulin secretion in rat islets in vitro]. Zhongguo Zhong Yao Za Zhi 34: 1401-1405, 2009.